BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 15367620)

  • 1. Human immunodeficiency virus type 1 (HIV-1) antigen secretion by latently infected resting CD4+ T lymphocytes from HIV-1-infected individuals.
    Fondere JM; Petitjean G; Huguet MF; Salhi SL; Baillat V; Macura-Biegun A; Becquart P; Reynes J; Vendrell JP
    J Virol; 2004 Oct; 78(19):10536-42. PubMed ID: 15367620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals.
    Chun TW; Justement JS; Lempicki RA; Yang J; Dennis G; Hallahan CW; Sanford C; Pandya P; Liu S; McLaughlin M; Ehler LA; Moir S; Fauci AS
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1908-13. PubMed ID: 12552096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
    Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unintegrated HIV-1 provides an inducible and functional reservoir in untreated and highly active antiretroviral therapy-treated patients.
    Petitjean G; Al Tabaa Y; Tuaillon E; Mettling C; Baillat V; Reynes J; Segondy M; Vendrell JP
    Retrovirology; 2007 Aug; 4():60. PubMed ID: 17727722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro reactivation of human immunodeficiency virus 1 from latently infected, resting CD4+ T cells after bacterial stimulation.
    Moriuchi H; Moriuchi M; Mizell SB; Ehler LA; Fauci AS
    J Infect Dis; 2000 Jun; 181(6):2041-4. PubMed ID: 10837189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enumeration of latently infected CD4+ T cells from HIV-1-infected patients using an HIV-1 antigen ELISPOT assay.
    Fondere JM; Planas JF; Huguet MF; Baillat V; Bolos F; Reynes J; Vendrell JP
    J Clin Virol; 2004 Jan; 29(1):33-8. PubMed ID: 14675867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.
    Chun TW; Carruth L; Finzi D; Shen X; DiGiuseppe JA; Taylor H; Hermankova M; Chadwick K; Margolick J; Quinn TC; Kuo YH; Brookmeyer R; Zeiger MA; Barditch-Crovo P; Siliciano RF
    Nature; 1997 May; 387(6629):183-8. PubMed ID: 9144289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patients.
    Monie D; Simmons RP; Nettles RE; Kieffer TL; Zhou Y; Zhang H; Karmon S; Ingersoll R; Chadwick K; Zhang H; Margolick JB; Quinn TC; Ray SC; Wind-Rotolo M; Miller M; Persaud D; Siliciano RF
    J Virol; 2005 Apr; 79(8):5185-202. PubMed ID: 15795302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of HIV-1-infected resting CD4+ T lymphocytes in breast milk.
    Petitjean G; Becquart P; Tuaillon E; Al Tabaa Y; Valea D; Huguet MF; Meda N; Van de Perre P; Vendrell JP
    J Clin Virol; 2007 May; 39(1):1-8. PubMed ID: 17387039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.
    Chun TW; Davey RT; Ostrowski M; Shawn Justement J; Engel D; Mullins JI; Fauci AS
    Nat Med; 2000 Jul; 6(7):757-61. PubMed ID: 10888923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals.
    Siliciano JD; Siliciano RF
    Methods Mol Biol; 2005; 304():3-15. PubMed ID: 16061962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
    J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection.
    Blankson JN; Finzi D; Pierson TC; Sabundayo BP; Chadwick K; Margolick JB; Quinn TC; Siliciano RF
    J Infect Dis; 2000 Dec; 182(6):1636-42. PubMed ID: 11069234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro induction of HIV-1 replication in resting CD4(+) T cells derived from individuals with undetectable plasma viremia upon stimulation with human T-cell leukemia virus type I.
    Moriuchi H; Moriuchi M
    Virology; 2000 Dec; 278(2):514-9. PubMed ID: 11118373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and quantification of proviral HIV-1 184 M/V in circulating CD4(+) T cells of patients on HAART with a viremia less than 1,000 copies/ml.
    Mohey R; Jørgensen LB; Møller BK; Black FT; Kjems J; Obel N
    J Clin Virol; 2005 Dec; 34(4):257-67. PubMed ID: 16286049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
    Li XD; Moore B; Cloyd MW
    Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy.
    Shen A; Zink MC; Mankowski JL; Chadwick K; Margolick JB; Carruth LM; Li M; Clements JE; Siliciano RF
    J Virol; 2003 Apr; 77(8):4938-49. PubMed ID: 12663799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.
    Persaud D; Pierson T; Ruff C; Finzi D; Chadwick KR; Margolick JB; Ruff A; Hutton N; Ray S; Siliciano RF
    J Clin Invest; 2000 Apr; 105(7):995-1003. PubMed ID: 10749578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A reservoir for HIV in patients on combination antiretroviral therapy.
    Siliciano RF
    Hopkins HIV Rep; 1998 Jan; 10(1):1, 5-6, 11. PubMed ID: 11365130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.